Sign up to save your podcasts
Or
Share E123: Upadacitinib for Giant Cell Arteritis: SELECT-GCA
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
E123: Upadacitinib for Giant Cell Arteritis: SELECT-GCA
Podcast this week about the recently published SELECT-GCA study, which evaluated the use of the janus kinase inhibitor upadacitinib (Rinvoq) for patients with new and relapsing GCA. Successful trial and an interesting topic. Paper itself here: https://www.nejm.org/doi/full/10.1056/NEJMoa2413449
View all episodes
By Michael Putman
4.9
113113 ratings
Podcast this week about the recently published SELECT-GCA study, which evaluated the use of the janus kinase inhibitor upadacitinib (Rinvoq) for patients with new and relapsing GCA. Successful trial and an interesting topic. Paper itself here: https://www.nejm.org/doi/full/10.1056/NEJMoa2413449
More shows like The Evidence Based Rheumatology Podcast
View all
NEJM This Week
322 Listeners
JAMA Clinical Reviews
502 Listeners
This Week in Cardiology
883 Listeners
Rheumnow Podcast
127 Listeners
Core IM | Internal Medicine Podcast
1,157 Listeners
Healio Rheuminations
119 Listeners
Annals On Call Podcast
193 Listeners
Freely Filtered, a NephJC Podcast
172 Listeners
ACR on Air
69 Listeners
Run the List
254 Listeners
Around the Rheum
4 Listeners
Rheumatology For The Royal College
182 Listeners
RheumMadness Rheumatology Podcast
11 Listeners
ACR Journals On Air
20 Listeners
Talking Rheumatology Spotlight
5 Listeners